Olocan Eye Drop contains Olopatadine 0.1% w/v, an effective antihistamine and mast cell stabilizer indicated for the treatment of allergic conjunctivitis. Olopatadine acts by selectively inhibiting histamine H1 receptors and preventing the release of inflammatory mediators from mast cells, thereby reducing ocular itching, redness, and swelling associated with allergic reactions. This ophthalmic solution is designed for topical application to the eyes, providing rapid relief from symptoms such as itching, watering, and redness caused by seasonal or perennial allergic conjunctivitis. Olocan Eye Drop is typically administered as one drop in the affected eye(s) twice daily or as directed by a healthcare professional. It is well-tolerated with minimal systemic absorption, reducing the risk of systemic side effects. Patients should avoid touching the dropper tip to the eye or any surface to prevent contamination. Use with caution in individuals with hypersensitivity to Olopatadine or any other components of the formulation. Olocan Eye Drop is contraindicated in patients with known hypersensitivity to any ingredient. Consult a healthcare provider if symptoms persist or worsen after use. This medication is intended for ophthalmic use only and should be stored at room temperature, protected from light.